A Phase III study comparing single-agent olaparib or the

Project: Research project

Project Details

Description

A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer
StatusActive
Effective start/end date10/1/169/30/20

Funding

  • NRG ONCOLOGY FOUNDATION, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.